FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307991189> ?p ?o ?g. }

• W4307991189 endingPage "A50" @default.
• W4307991189 startingPage "A50" @default.
• W4307991189 abstract "Abstract We report a patient with combined pulmonary arterial hypertension (PAH) and autoimmune polyglandular syndrome (APS) type 2. A 41 y/o woman with hypothyroidism presented for right heart (RHC) in the work up of PAH. Pt had a medical history of PAH diagnosed by transthoracic echocardiogram (TTE) and hypothyroidism. She reported symptoms of fatigue, shortness of breath with increased pigmentation of her skin progressive for several years. Preadmission lab found hyponatremia of 126 and potassium of 6.6. She was admitted and treated with IV insulin with D50, kayexalate, IV fluids. A random 11 AM cortisol was 0.57 mcg/dl N: AM: 6. 0–30. 0 mcg/dl; PM: 3. 0–16. 0 mcg/dl. Acosyntropin test was ordered. Pt failed the stimulation test (baseline 0.39, 30 min 0.49, 60 min 0.50, with an ACTH at baseline of 1423 pg/ml N: 7.2-63.3). Pt was started on hydrocortisone 20 mg AM/10 mg PM with fludrocortisone 0.1mg. On follow up at 2 weeks, her energy, mood, appetite and breathing tolerance had improved. Follow up RHC in 4 weeks found normalization of right heart pressures. APS is a collection of autoimmune diseases. Type I APS, caused by a defect in the autoimmune regulator (AIRE) gene, is diagnosed with two of three conditions, chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal cortical insufficiency. Type II APS (formally Schmidt's Syndrome), associated with HLA haplotypes DR3 (DQB*0201) and DR4 (DQB1*0302), is diagnosed with chronic autoimmune adrenal insufficiency with either Type 1 DM or chronic autoimmune thyroid disease (commonly Hashimotos but can be Graves). It typically presents later in life compared to APS I, age 30-40s. The association between PAH is rare but has been noted in several case studies. It has been associated with APS I in Korniszewski et al. and Bhansali et al. For APS II, the first association was reported by Barrou et al. of a patient with hypothyroidism, hypogonadism, and adrenal insufficiency who later developed PAH. Two cases reported by García-Hernández et al found PAH with positive adrenal antibodies without adrenal insufficiency. In 2009 Walid R. et al. reported a case of severe adrenal insufficiency (hypotension, hypokalemia) with PAH. She improved with steroids, but her PAH was present on TTE four years after treatment started. Pt in that case declined RHC. The patient in this case study proceeded with a RHC which did show normalization of right heart pressures, the first reported case to document normalization of PAH with replacement steroid treatment. Presentation: No date and time listed" @default.
• W4307991189 created "2022-11-07" @default.
• W4307991189 creator A5046772798 @default.
• W4307991189 creator A5066816962 @default.
• W4307991189 date "2022-11-01" @default.
• W4307991189 modified "2023-09-30" @default.
• W4307991189 title "ODP019 A Case Study of the Association of Autoimmune Polyglandular Syndrome and Pulmonary Artery Hypertension" @default.
• W4307991189 doi "https://doi.org/10.1210/jendso/bvac150.103" @default.
• W4307991189 hasPublicationYear "2022" @default.
• W4307991189 type Work @default.
• W4307991189 citedByCount "0" @default.
• W4307991189 crossrefType "journal-article" @default.
• W4307991189 hasAuthorship W4307991189A5046772798 @default.
• W4307991189 hasAuthorship W4307991189A5066816962 @default.
• W4307991189 hasBestOaLocation W43079911891 @default.
• W4307991189 hasConcept C126322002 @default.
• W4307991189 hasConcept C134018914 @default.
• W4307991189 hasConcept C164705383 @default.
• W4307991189 hasConcept C2775941721 @default.
• W4307991189 hasConcept C2776899810 @default.
• W4307991189 hasConcept C2777955127 @default.
• W4307991189 hasConcept C2778129406 @default.
• W4307991189 hasConcept C2778198053 @default.
• W4307991189 hasConcept C2778709874 @default.
• W4307991189 hasConcept C2780940725 @default.
• W4307991189 hasConcept C71924100 @default.
• W4307991189 hasConcept C90924648 @default.
• W4307991189 hasConceptScore W4307991189C126322002 @default.
• W4307991189 hasConceptScore W4307991189C134018914 @default.
• W4307991189 hasConceptScore W4307991189C164705383 @default.
• W4307991189 hasConceptScore W4307991189C2775941721 @default.
• W4307991189 hasConceptScore W4307991189C2776899810 @default.
• W4307991189 hasConceptScore W4307991189C2777955127 @default.
• W4307991189 hasConceptScore W4307991189C2778129406 @default.
• W4307991189 hasConceptScore W4307991189C2778198053 @default.
• W4307991189 hasConceptScore W4307991189C2778709874 @default.
• W4307991189 hasConceptScore W4307991189C2780940725 @default.
• W4307991189 hasConceptScore W4307991189C71924100 @default.
• W4307991189 hasConceptScore W4307991189C90924648 @default.
• W4307991189 hasIssue "Supplement_1" @default.
• W4307991189 hasLocation W43079911891 @default.
• W4307991189 hasLocation W43079911892 @default.
• W4307991189 hasOpenAccess W4307991189 @default.
• W4307991189 hasPrimaryLocation W43079911891 @default.
• W4307991189 hasRelatedWork W1966798818 @default.
• W4307991189 hasRelatedWork W1971159013 @default.
• W4307991189 hasRelatedWork W1981171782 @default.
• W4307991189 hasRelatedWork W1994557505 @default.
• W4307991189 hasRelatedWork W2008197398 @default.
• W4307991189 hasRelatedWork W2018289004 @default.
• W4307991189 hasRelatedWork W2045808740 @default.
• W4307991189 hasRelatedWork W2066590152 @default.
• W4307991189 hasRelatedWork W2078224059 @default.
• W4307991189 hasRelatedWork W4241864131 @default.
• W4307991189 hasVolume "6" @default.
• W4307991189 isParatext "false" @default.
• W4307991189 isRetracted "false" @default.
• W4307991189 workType "article" @default.